» Articles » PMID: 28102034

Common and Well-documented HLA Alleles over All of Europe and Within European Sub-regions: A Catalogue from the European Federation for Immunogenetics

Overview
Journal HLA
Date 2017 Jan 20
PMID 28102034
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A catalogue of common and well-documented (CWD) human leukocyte antigen (HLA), previously established by the American Society for Histocompatibility and Immunogenetics (ASHI), is widely used as indicator for typing ambiguities to be resolved in tissue transplantation or for checking the universality of any HLA allele in the world. However, European population samples, which are characterized by a substantial level of genetic variation, are underrepresented in the ASHI catalogue. Therefore, the Population Genetics Working Group of the European Federation for Immunogenetics (EFI) has facilitated data collection for an European CWD catalogue.

Materials And Methods: To this end, 2nd-field HLA-A, -B, -C,- DRB1,- DQA1,- DQB1 and -DPB1 data of 77 to 121 European population samples (21 571-3 966 984 individuals) from 3 large databases, HLA-net/Gene[VA], allelefrequencies.net and DKMS, were analysed.

Results: The total number of CWD alleles is similar in the EFI (N = 1048) and ASHI (N = 1031) catalogues, but the former counts less common (N = 236 vs 377) and more well-documented (N = 812 vs 654) alleles than the latter, possibly reflecting differences in sample numbers and sizes. Interestingly, approximately half of the CWD alleles reported by EFI were not reported by ASHI and vice-versa, underlining the distinct features of the two catalogues. Also, although 78 common alleles are widely distributed across Europe, some alleles are only common within specific sub-regions, showing regional variability.

Conclusion: Although the definition of CWD alleles itself is affected by different parameters, calling for current updates of the list, the EFI CWD catalogue provides new insights into European population genetics and will be a very useful tool for tissue-typing laboratories in and beyond Europe.

Citing Articles

Comprehensive Characterization of Anti-HLA and Non-HLA Antibodies in Patients on Kidney Transplant Waiting List and Evaluation of Their Impact on Alloimmunization Risk and Dialysis Treatment.

Mujic Franic A, Lilic M, Katalinic N, Glavas-Obrovac L Int J Mol Sci. 2024; 25(22).

PMID: 39596170 PMC: 11593988. DOI: 10.3390/ijms252212103.


Prognostic Role of Human Leukocyte Antigen Alleles and Cytokine Single-Nucleotide Polymorphisms in Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitor Drugs.

Birru S, Doxiadis I, Howe R, Kelemu T, Chala S, Sherif A Genes (Basel). 2024; 15(6).

PMID: 38927668 PMC: 11203291. DOI: 10.3390/genes15060732.


HLA alleles, haplotypes frequencies, and their association with hematological disorders: a report from 1550 families whose patients underwent allogeneic bone marrow transplantation in Egypt.

ElNahass Y, Mekky N, Abdelfattah N, Abdelfattah R, Samra M, Fahmy O Immunogenetics. 2024; 76(4):243-260.

PMID: 38904751 DOI: 10.1007/s00251-024-01343-x.


Regional European genetic ancestry predicts type I interferon level and risk of severe viral infection.

Nln I, Shum J, Ghodke-Puranik Y, Tipon R, Triese D, Amin S QJM. 2024; 117(8):581-588.

PMID: 38530799 PMC: 11389909. DOI: 10.1093/qjmed/hcae052.


HLA Genetics for the Human Diseases.

Shiina T, Kulski J Adv Exp Med Biol. 2024; 1444:237-258.

PMID: 38467984 DOI: 10.1007/978-981-99-9781-7_16.